Our Affiliations
The Sampson Lab is proudly affiliated with Boston Children’s Hospital’s Nephrology Division. Boston Children’s Hospital is dedicated to improving and advancing the health and well-being of children around the world through its life-changing work in clinical care, biomedical research, medical education and community engagement. Additionally, Boston Children’s Nephrology Division has one of the largest and longest-established research programs in childhood kidney disease in the world.
The Broad Institute of MIT and Harvard is a scientific research center in Cambridge that is composed of faculty members from across the Harvard and MIT system. Scientists at the Broad strive to answer diverse questions in biomedical research using established and cutting edge technologies and methods. Within the Broad is the Kidney Disease Initiative (KDI) led by Dr. Anna Greka. The Sampson Lab is part of the KDI, and works together with other Broad investigators to uncover the molecular causes of kidney diseases in order to develop precision, mechanism-based therapies.
NEPTUNE is a multicenter, international research consortium that strives to discover the molecular causes of nephrotic syndrome, how nephrotic syndrome impacts patients and more precise and effective ways to treat the disease. The Sampson Lab helps contribute to genomic data generation and discovery within the NEPTUNE consortium.
ClinGen is a National Institutes of Health (NIH)-funded group dedicated to building a central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. The Kidney Disease Working Group, led by Drs. Andrew Mallett and Matt Sampson, focuses on creating a comprehensive, standardized knowledge base of genes and variants relevant to kidney genetic and genomic medicine.
Dr. Matt Sampson also has a faculty appointment with Brigham and Women’s Hospital’s Division of Renal (Kidney) Medicine. Brigham and Women’s Hospital is dedicated to providing expert, compassionate patient care and creating an innovative and collaborative research environment.
Boston Children’s Hospital is the primary pediatric program of Harvard Medical School, which is located next to the hospital. There are more than 3000 Harvard Medical School faculty affiliated with Boston Children’s Hospital. All post-doctoral fellows in the Sampson Lab have their appointments through Harvard Medical School.
CureGN is a multicenter observational cohort study of the following glomerular diseases: Minimal Change Disease (MCD), Focal Segmental Glomerulosclerosis (FSGS), Membranous Nephropathy (MN), and IgA Nephropathy (IgAN and IgAV). They have a large network of clinical sites across the United States, Canada, and Europe.
The International Society of Glomerular Disease (ISGD) is a medical society that provides a physician- and researcher-centric professional home for glomerular disease experts. ISGD was initially envisioned by NephCure and has been spun off as an independent nonprofit organization. In recent decades there has been exponential advances in glomerular medicine. ISGD seeks to ensure equitable care for patients with glomerular disease.
The recurrent focal segmental glomerulosclerosis (rFSGS) consortium brings together patients, families, doctors, researchers, and supporters to share experiences, raise awareness, and work toward finding new resources and funding for research. rFSGS is a rare kidney disease that can reappear after a kidney transplant, with limited treatment options currently available.
Their goal is to advance science and support efforts to develop more effective treatments for rFSGS, helping both children and adults affected by this challenging condition.